Capital World Investors - NEVRO CORP ownership

NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 176 filers reported holding NEVRO CORP in Q3 2018. The put-call ratio across all filers is 0.57 and the average weighting 0.1%.

Quarter-by-quarter ownership
Capital World Investors ownership history of NEVRO CORP
ValueSharesWeighting
Q4 2022$10,018,800
-15.0%
253,0000.0%0.00%
-33.3%
Q3 2022$11,790,000
+6.3%
253,0000.0%0.00%
+50.0%
Q2 2022$11,089,000
-39.4%
253,0000.0%0.00%
-33.3%
Q1 2022$18,299,000
-10.8%
253,0000.0%0.00%0.0%
Q4 2021$20,511,000
-30.3%
253,0000.0%0.00%
-40.0%
Q3 2021$29,444,000
-29.8%
253,0000.0%0.01%
-28.6%
Q2 2021$41,945,000
+18.8%
253,0000.0%0.01%0.0%
Q1 2021$35,294,000
+27.4%
253,000
+58.1%
0.01%
+40.0%
Q4 2020$27,696,000
+24.3%
160,0000.0%0.01%0.0%
Q3 2020$22,288,000
+16.6%
160,0000.0%0.01%0.0%
Q2 2020$19,115,000
+19.5%
160,0000.0%0.01%0.0%
Q1 2020$15,997,000
-14.9%
160,0000.0%0.01%
+25.0%
Q4 2019$18,806,000
+36.7%
160,0000.0%0.00%
+33.3%
Q3 2019$13,755,000
+32.6%
160,0000.0%0.00%
+50.0%
Q2 2019$10,373,000
+3.7%
160,0000.0%0.00%0.0%
Q1 2019$10,002,000
+60.8%
160,0000.0%0.00%0.0%
Q4 2018$6,222,000
-31.8%
160,0000.0%0.00%0.0%
Q3 2018$9,120,000
-28.6%
160,0000.0%0.00%
-33.3%
Q2 2018$12,776,000
-7.9%
160,0000.0%0.00%0.0%
Q1 2018$13,867,000
+25.5%
160,0000.0%0.00%
+50.0%
Q4 2017$11,046,000
-24.0%
160,0000.0%0.00%
-33.3%
Q3 2017$14,541,000
+22.1%
160,0000.0%0.00%0.0%
Q2 2017$11,909,000
-20.6%
160,0000.0%0.00%
-25.0%
Q1 2017$14,992,000
+55.1%
160,000
-36.0%
0.00%
+33.3%
Q4 2014$9,668,000250,0000.00%
Other shareholders
NEVRO CORP shareholders Q3 2018
NameSharesValueWeighting ↓
Iron Triangle Partners LP 562,833$40,710,0004.84%
Altium Capital Management LP 77,000$5,569,0001.86%
PFM Health Sciences, LP 649,513$46,979,0001.76%
Rock Springs Capital Management LP 721,500$52,186,0001.31%
Integral Health Asset Management, LLC 50,000$3,617,0000.94%
Redmile Group, LLC 411,017$29,729,0000.93%
K2 PRINCIPAL FUND, L.P. 114,800$8,303,0000.72%
Connacht Asset Management LP 18,762$1,357,0000.70%
Perceptive Advisors 477,037$34,504,0000.69%
ArrowMark Colorado Holdings LLC 855,439$61,874,0000.54%
View complete list of NEVRO CORP shareholders